|
Sertraline Clinical Trials
9 actively recruiting trials across 4 locations
Also known as: ATC code: N06AB06, Non-responder Meds, Serotonin Reuptake Inhibitor, Sertraline Hydrochloride, Zoloft
Pipeline
Phase 2: 3Phase 3: 2Phase 4: 2Phase 1/2: 1
Top Sponsors
- Dr. Inge Winter2
- University of Texas at Austin1
- University of Cincinnati1
- Stanford University1
- Holland Bloorview Kids Rehabilitation Hospital1
Indications
- Depression6
- Major Depressive Disorder3
- Anxiety3
- Bipolar Depression2
- Anxiety Disorders2
Other5 trials
Palo Alto, California1 trial
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression
Stanford Psychiatry and Behavioral Sciences Department
Phase 2
Boston, Massachusetts1 trial
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Center for Anxiety and Related Disorders at Boston University
N/A
Cincinnati, Ohio1 trial
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
University of Cincinnati
Phase 4
Austin, Texas1 trial
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.